Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CALL
Ferrari
RACE
$72.9B
| $14.3M | 0.01% |
83,500
-8,700
| -9% | -$1.4M |
|
1702
Haemonetics
HAE
$4.13B
| $14.3M | 0.01% |
159,390
+50,607
| +47% | +$5.11M |
|
1703
FS KKR Capital
FSK
$3.42B
| $14.3M | 0.01% |
1,018,233
+381,265
| +60% | +$5.37M |
|
1704
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $14.2M | 0.01% |
116,600
+9,000
| +8% | +$995K |
|
1705
CALL
Vulcan Materials
VMC
$36.5B
| $14.2M | 0.01% |
122,600
+39,300
| +47% | +$4.3M |
|
|
MYOK
1706
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $14.2M | 0.01% |
146,932
+109,028
| +288% | +$9.09M |
|
1707
PUT
United States Natural Gas Fund
UNG
$487M
| $14.2M | 0.01% |
345,725
-386,825
| -53% | -$18.4M |
|
1708
PUT
Cardinal Health
CAH
$54.7B
| $14.2M | 0.01% |
271,700
+24,800
| +10% | +$1.28M |
|
1709
Papa John's
PZZA
$799M
| $14.2M | 0.01% |
178,262
-456,337
| -72% | -$33.9M |
|
1710
CALL
NetApp
NTAP
$40.6B
| $14.2M | 0.01% |
318,900
+69,500
| +28% | +$2.99M |
|
1711
CALL
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $14.2M | 0.01% |
90,400
-4,800
| -5% | -$708K |
|
1712
Capri Holdings
CPRI
$1.74B
| $14.1M | 0.01% |
903,876
-2,931,701
| -76% | -$43.4M |
|
|
CZR
1713
DELISTED
Caesars Entertainment Corporation
CZR
| $14.1M | 0.01% |
1,162,111
-6,228,707
| -84% | -$62.9M |
|
1714
CALL
W.W. Grainger
GWW
$62.3B
| $14M | 0.01% |
44,700
-8,200
| -16% | -$2.37M |
|
1715
Armstrong World Industries
AWI
$7.7B
| $14M | 0.01% |
179,818
-97,677
| -35% | -$7.4M |
|
1716
CALL
iShares Core S&P 500 ETF
IVV
$908B
| $14M | 0.01% |
45,200
-39,200
| -46% | -$11.5M |
|
|
MRSN
1717
DELISTED
Mersana Therapeutics
MRSN
| $14M | 0.01% |
23,928
+5,481
| +30% | +$1.87M |
|
1718
CALL
Deckers Outdoor
DECK
$12.7B
| $14M | 0.01% |
427,200
+105,000
| +33% | +$2.89M |
|
1719
PUT
Johnson Controls International
JCI
$93.1B
| $14M | 0.01% |
409,100
+314,000
| +330% | +$9.66M |
|
1720
PUT
Cleveland-Cliffs
CLF
$6.79B
| $14M | 0.01% |
2,528,700
+1,004,600
| +66% | +$4.88M |
|
1721
Thermo Fisher Scientific
TMO
$218B
| $13.9M | 0.01% |
38,466
-350,677
| -90% | -$118M |
|
1722
GDS Holdings
GDS
$6.89B
| $13.9M | 0.01% |
174,937
-613,106
| -78% | -$37.9M |
|
1723
uniQure
QURE
$3.37B
| $13.9M | 0.01% |
308,945
+244,817
| +382% | +$14.5M |
|
1724
CALL
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$534M
| $13.9M | 0.01% |
126,000
+310
| +0.2% | +$26.1K |
|
1725
PUT
Equitable Holdings
EQH
$14.5B
| $13.9M | 0.01% |
+720,000
| New | +$12.9M |
|
Similar funds
Citadel Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.
- Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
- Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.